Literature DB >> 15833159

[Oral glucose tolerance and insulin release test in 52 cases of obese and overweight children].

Wen-xin Sun1, Wei Wang, De-fen Wang, Yi-fen Cui.   

Abstract

OBJECTIVE: To assess the state of glucose metabolism and beta-cell function in obese and overweight children.
METHODS: Levels of glucose and insulin were detected during oral glucose tolerance test in 52 obese and overweight children aged 11.3 +/- 1.8 years with body mass index (BMI) 30.2 +/- 19.2 kg/m(2). Insulin resistance index (IR = FIN x FPG/22.5), insulin sensitivity index (IS = 1/FIN x FPG) and ratio of insulin increment to glucose increment at 30' (I(30)-I(0)/G(30)-G(0)) post oral glucose were measured. (FIN = fasting insulin. FPG = fasting plasma glucose). The IR, IS and the ratio post oral glucose were compared among groups with varying BMI and between groups of impaired glucose tolerance (IGT) and control. Serum triglyceride determination and B ultrasonography of liver were performed.
RESULTS: (1) one patient with type 2 diabetes (1.9%) and 5 patients with IGT (9.6%) were found. (2) IR (> or = 2.8) was observed in 76.9% of the cases. (3) The IR, IS and their ratio showed no difference between the compared groups. (4) IR and IS did not show significant difference but there was significant difference in ratio between the IGT and control group. (5) Increased serum triglyceride and fatty liver were noted in 36.5% and 53.3% of the cases, respectively.
CONCLUSION: The results indicated that insulin resistance and reduced insulin sensitivity in obese and overweight children are common, and these changes seemed not to correlated with the varying degree of BMI. Beta-cells function was obviously impaired in obese children with IGT and disorder of lipid metabolism exists in many obese and overweight children revealed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833159

Source DB:  PubMed          Journal:  Zhonghua Er Ke Za Zhi        ISSN: 0578-1310


  1 in total

1.  Glucose metabolism disorder in obese children assessed by continuous glucose monitoring system.

Authors:  Chao-Chun Zou; Li Liang; Fang Hong; Zheng-Yan Zhao
Journal:  World J Pediatr       Date:  2008-02       Impact factor: 2.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.